Scientists have discovered a new metabolic process in the body that can switch off inflammation. They have discovered that ‘itaconate’ – a molecule derived from glucose – acts as a powerful off-switch for macrophages, which are the cells in the immune system that lie at the heart of many inflammatory diseases including arthritis, inflammatory bowel disease and heart disease.
The scientists, working in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute at Trinity College Dublin, hope their discovery will have relevance for inflammatory and infectious diseases – and that their findings may also help to develop much-needed new drugs to treat people living with these conditions.
Professor of Biochemistry at Trinity, Luke O’Neill, was, along with Dr Mike Murphy of the University of Cambridge, the joint leader of the work just published in leading international journal Nature. The discoveries were made using both human cells and mice as a model organism.
Professor O’Neill said: “My lab has been exploring metabolic changes in macrophages for the past six years and we’ve come across what we think is the most important finding yet.”
“It is well known that macrophages cause inflammation, but we have just found that they can be coaxed to make a biochemical called itaconate. This functions as an important brake, or off-switch, on the macrophage, cooling the heat of inflammation in a process never before described.”
Dr Evanna Mills, who, with Dylan Ryan was joint first author of the work, said: “The macrophage takes the nutrient glucose, whose day job it is to provide energy, and surprisingly turns it into itaconate. This then blocks production of inflammatory factors, and also protects mice from the lethal inflammation that can occur during infection.”
Dylan Ryan added: “We’ve found that itaconate can directly modify a whole host of proteins important for inflammation in a chemical reaction never before described, and that this reaction is important for the anti-inflammatory effects of itaconate.”
The discovery is very much on the frontier of inflammation research and Professor O’Neill and his collaborators are now exploring its relevance to the onset and development of inflammatory and infectious diseases. They are also keen to explore whether the findings can be exploited in the effort to develop new anti-inflammatory medicines.
The work was a collaboration with Harvard Medical School, the University of Cambridge, the University of Oxford, Johns Hopkins University, the University of Dundee, and GlaxoSmithKline, where both Professor O’Neill and Dr Mills spent time on sabbatical.
Professor O’Neill said: “This discovery and the new research pathways it has opened up will keep us busy for some time but we are hopeful that it will one day make a difference to patients with diseases that remain difficult to treat.”
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- Inflammation in late teens linked to mortality risk decades lateron September 6, 2019 at 3:05 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current ...
- Cubs place closer Craig Kimbrel on 10-day injured list with elbow inflammationon September 5, 2019 at 7:08 pm
Just when the Cubs appeared to be getting back to full strength, they hit another bump in the road. Ahead of Thursday's game against the Brewers, Theo Epstein announced that the Cubs placed closer ...
- Cubs place Craig Kimbrel on injured list with right elbow inflammationon September 5, 2019 at 5:07 pm
The rest of Cubs closer Craig Kimbrel’s season could be in jeopardy after the team placed the veteran reliever on the 10-day injured list with right elbow inflammation late Thursday afternoon. The ...
- Cubs' Craig Kimbrel placed on injured list with elbow inflammationon September 5, 2019 at 5:06 pm
Chicago Cubs closer Craig Kimbrel is headed to the injured list for the second time since joining the team in June, team president Theo Epstein told reporters Thursday. While the last time he was ...
- Cubs closer Craig Kimbrel goes on IL with elbow inflammationon September 5, 2019 at 3:18 pm
MILWAUKEE — Chicago Cubs closer Craig Kimbrel was put on the injured list with elbow inflammation on Thursday ahead of a big series against the Milwaukee Brewers. Kimbrel hasn’t pitched since allowing ...
- Cubs Place Ex-Red Sox Closer Craig Kimbel On IL With Elbow Inflammationon September 5, 2019 at 3:17 pm
Craig Kimbrel is heading to the injured list. Chicago Cubs president of baseball operations Theo Epstein announced Thursday that the ex-Boston Red Sox closer has been placed on the injured list ...
- Cubs CP Craig Kimbrel lands on IL with elbow inflammationon September 5, 2019 at 3:09 pm
As the Chicago Cubs prepare for a critical stretch in September and a heated playoff race, they’ll now have to do it without All-Star closer Craig Kimbrel for the foreseeable future. Cubs general ...
- Cubs closer Craig Kimbrel goes back to the 10-day IL with elbow inflammationon September 5, 2019 at 3:05 pm
MILWAUKEE – At this time of the season, the last thing that Joe Maddon needs is to have the man closing out games out of his bullpen. But that’s the situation for the Cubs’ manager as the ...
- Craig Kimbrel injury: Cubs place Ex-Boston Red Sox closer on IL with elbow inflammationon September 5, 2019 at 2:57 pm
The Cubs placed ex-Red Sox closer Craig Kimbrel on the injured list with elbow inflammation Thursday, team president of baseball operations Theo Epstein told reporters in Chicago. According to ESPN’s ...
via Bing News